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SUMMARY
Members of the SH2 domain family modulate signal
transduction by binding to short peptides containing
phosphorylated tyrosines. Each domain displays
a distinct preference for the sequence context of
the phosphorylated residue. We have developed
a high-density peptide chip technology that allows
for probing of the affinity of most SH2 domains for
a large fraction of the entire complement of tyrosine
phosphopeptides in the human proteome. Using
this technique, we have experimentally identified
thousands of putative SH2-peptide interactions for
more than 70 different SH2 domains. By integrating
this rich data set with orthogonal context-specific
information, we have assembled an SH2-mediated
probabilistic interaction network, which we make
available as a community resource in the PepspotDB
database. A predicted dynamic interaction between
the SH2 domains of the tyrosine phosphatase SHP2
and the phosphorylated tyrosine in the extracellular
signal-regulated kinase activation loopwas validated
by experiments in living cells.
INTRODUCTION
Posttranslational modifications (PTMs) and modular protein
domains underlie dynamic protein interaction networks and
represent one of the key organizing principles in cellular
systems (Pawson, 2004). In particular, kinases modulate cell
response to growth signals by adding phosphate groups to
short linear sequence motifs in their substrates. These phos-
phorylated residues in turn serve as docking sites for proteins
containing phospho-binding modules such as the SH2, PTB,
and BRCT domains (Yaffe, 2002). The SH2 domain family
includes a total of 120 domains in 110 proteins and, as such,
represents the largest class of tyrosine phosphopeptide recog-
nition domains (Liu et al., 2006). The peptide recognition prefer-
ence of each member of this large domain family has been the
subject of a number of studies with genome-wide perspectives.
The pioneering work of Cantley’s group exploited oriented
peptide libraries to characterize the preference for specific resi-
dues in the positions flanking the phosphorylated tyrosine in the
targets of 14 SH2 domains (Songyang et al., 1993). Machida
and collaborators used a far-western approach and a new
strategy termed ‘‘reverse-phase protein array’’ to profile nearly
the full complement of the SH2 domain family (Machida et al.,
2007). This strategy allowed for the classification of SH2
domains according to their ability to bind classes of phosphor-
ylated proteins, but lacked sufficient resolution to precisely
define recognition specificity and to permit the identification
of the targets of each SH2-containing protein. Another
approach exploited OPAL, a variant of the oriented peptide
library approach, to derive position-specific scoring matrices
for 76 of the 120 human SH2 domains (Huang et al., 2008).
Finally, the full complement of human SH2 domains was ar-
rayed on glass chips and probed with a collection of phospho-
tyrosine peptides from the ErbB receptor family (Jones et al.,
2006). This latter strategy offers the advantages of directly ad-
dressing the interactions with specific phosphopeptides from
the human proteome and of being amenable to quantitative
analysis. However, the throughput of its present implementa-
tion does not permit screening of the entire human phospho-
proteome. These approaches have represented a considerable
advancement in our understanding of the recognition specificity
within this domain family, and together they have contributed to
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the characterization of approximately two-thirds of the SH2
domains.
We have addressed the problem from a different angle by
developing and exploiting a new technology that permits us to
probe the recognition specificity of each phosphotyrosine
binding domain on a high-density peptide chip containing nearly
the full complement of tyrosine phosphopeptides in the human
proteome. In addition, we integrate these in vitro experimental
data with orthogonal genome-wide data sets to propose an
SH2-mediated probabilistic interaction network that takes into
account both in vitro affinity data and in vivo contextual
evidence. Finally, we have captured from the published literature
more than 800 pieces of experimental evidence pertaining to
SH2 recognition specificity, and we have used this information
as a gold standard to benchmark our predictors.
Our strategy combines harnessing the strengths of a powerful
experimental assay and integrating its quantitative output with
a wide range of orthogonal genome-wide context information.
The raw experimental data and the probabilistic network can
be accessed and explored in the context of the SH2 domain
interaction curated from the literature in a new publicly available
resource, the Pepspot database (PepspotDB; http://mint.bio.
uniroma2.it/PepspotDB/home.seam).
RESULTS AND DISCUSSION
Phosphotyrosine Peptide Chips: A Nearly Complete
Complement of the Human Phosphotyrosine Proteome
The SPOT synthesis approach (Frank, 1992) is based on the
ability to synthesize a few thousand oligopeptides in an ordered
array on a cellulose membrane. This approach has been used
extensively to study protein interactions when one of the part-
ners can be represented as a short unconstrained peptide. For
this project, we have moved forward the approach by increasing
by approximately one order of magnitude the number of
peptides that can be tested in a single experiment (Figure 1).
This is based on the ability to (1) synthesize several thousands
of peptides by spatially addressed SPOT synthesis, (2) punch-
press the peptide spots into wells of microtiter plates, (3) release
peptides from the resulting cellulose discs, and (4) print them
onto aldehyde-modified glass surfaces, which results in high-
density peptide chips displaying the probes in three identical
replicates.
The tyrosine phosphopeptide chip (pTyr-chip) used in this
work was initially designed to represent most of the phospho-
proteome known when this project started. At that time, the
Phospho.ELM (Diella et al., 2008) and PhosphoSite (Hornbeck
et al., 2004) databases contained 2,198 tyrosine phosphopep-
tides. This collection of experimentally determined phospho-
peptides was completed with approximately 4,000 additional
peptides having a high probability of being phosphorylated ac-
cording to the NetPhos predictor (Blom et al., 1999). Overall,
6,202 phosphopeptides, 13 residues long with the tyrosine
phosphopeptide in the middle position, were printed in tripli-
cate with the appropriate controls (Table S1). Each pTyr-chip
can be used to profile the recognition specificity of a phospho-
tyrosine binding domain fused to a tag and revealed with an
anti-tag fluorescent antibody.
Profiling the Recognition Specificity of the SH2 Domain
Family
The pTyr-chips were used to profile a collection of 99 human
SH2 domains fused to glutathione S-transferase (GST) (Table
S2) (Machida et al., 2007). Experimental reproducibility ranged
from 0.7 to 0.99 Pearson’s correlation coefficient (PCC), with
most results being well over 0.95, when two replica arrays are
compared (intrachip reproducibility), and of approximately 0.95
in two independent experiments carried out with two different
preparations of the same domain (interchip reproducibility) (see
Figure S1; Table S3).
Among the 99 domains in the collection, 26 did not express as
a soluble product and 3 gave a poor signal in the peptide chip
assay. Only experiments with replica arrays having a PCC higher
than 0.7 were considered for further analysis. Overall, 70
domains gave a satisfactory result by this approach. The speci-
ficity of 15 of them had, to our knowledge, never been described
before.
The sequences of the peptides whose binding signal ex-
ceeded the average signal by more than two SDs (Z score > 2)
were aligned and used to draw sequence logos illustrating the
preferred binding motif of each domain (Figure 2).
Differently from what has been recently described for PDZ,
SH3, and WW domains (Gfeller et al., 2011), we could not
find evidence for multiple specificities for any of the character-
ized SH2 domains. The results of the profiling experiments
were used to cluster the domains according to their preference
for phosphotyrosine sequence context (Figure 3A). Based on
the resulting tree, we arbitrarily define 17 specificity classes
characterized by representative amino acid sequence logos
(Figure 3B). In Figure 3C, we have drawn a second tree where
SH2 domains are clustered according to homology in their
primary sequence. Specificity class membership is illustrated
by background colors matching the colors in Figure 3A.
Although closely related domains tend to be members of the
same class, the correlation between sequence homology
over the whole domain and peptide recognition specificity is
overall poor (PCC = 0.30; Figure S2). This is consistent with
the results of Machida and collaborators (Machida et al.,
2007), who failed to identify a correlation between domain
sequence and band patterns in far-western type experiments.
Attempts to identify diagnostic residues that would help assign
uncharacterized domains to specificity classes using MultiHar-
mony software (Brandt et al., 2010) have not been successful.
The finding that little divergence in sequence homology can
account for relatively large changes in binding specificity is
consistent with the reported observations that a few amino
acid changes are sufficient to induce a specificity shift in
peptide recognition modules such as SH2, SH3, and PDZ
(Ernst et al., 2009; Marengere et al., 1994; Panni et al., 2002)
and has implications for the interpretation of the observed
rapid evolution of protein interaction networks (Kiemer and Ce-
sareni, 2007).
Liu and collaborators have proposed that nonpermissive
amino acid residues that oppose binding could play a role
in shaping SH2 domain recognition specificity (Liu et al.,
2010). We have confirmed that some SH2 ligands dislike
specific residues at specific positions (Figure S3). However,
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our comprehensive analysis failed to confirm that negative
selection could play a prominent role in modulating pep-
tide recognition specificity within the defined specificity
classes.
ANN Predictors of SH2 Binding
The pTyr-chip used in this work was initially designed to contain
most of the human phosphotyrosine peptides that were known
at the start of this project. However, recent developments in
Figure 1. Schematic Illustration of the Strategy Used to Draw an SH2-Mediated Protein Interaction Network
See also Figure S1 and Table S1.
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mass spectrometry-based technology have caused an explo-
sion of information, and the collection of phosphorylated
peptides contained in databases (Diella et al., 2008; Hornbeck
et al., 2004) now significantly exceeds the number of experimen-
tally verified peptides represented in our array. Thus, in order to
be able to offer a resource that could reliably infer the SH2
ligands of any recently discovered phosphopeptide, we devel-
oped artificial neural network (ANN) predictors (NetSH2) for
each of the 70 profiled SH2 domains (see Experimental
Procedures).
To utilize all the information from pTyr-chips, the peptide
sequences and normalized log-ratio intensities were used as
input for the ANN. In this way, we trained the ANNs to predict
if a given peptide is a weak or strong binder of a specific SH2
domain. In total, 70 predictors were trained with an average
PCC of 0.4 (Figure 4). These predictors have been integrated in
the Netphorest community resource (Miller et al., 2008).
Benchmarking the SH2 ANN Predictors
An independent large-scale effort has investigated the substrate
specificities of SH2 domains using oriented peptide libraries
(Huang et al., 2008). The results are available in a resource,
termed SMALI (scoring matrix-assisted ligand identification),
which uses position-specific scoring matrices (PSSMs) to
predict ligands of 76 different SH2 domains. The main difference
between PSSMs and ANNs is that the latter can capture
nonlinear correlations between residues. In order to compare
the performance of SMALI to the ANN developed here, we
compiled an independent benchmark data set of the known
in vivo ligands of SH2 domains. For this purpose, the information
from the MINT database was supplemented with new interac-
tions captured by an extensive search and curation of published
information (see Experimental Procedures). The integrated
interaction list (see Table S4 and Figure S4) was used as the
‘‘positive’’ benchmarking data set, while the ‘‘negative’’ data
set consisted of phosphotyrosine peptides from the Phos-
pho.ELM database (Diella et al., 2008) that had not been shown
to bind any SH2 domain. After discarding benchmark peptides
that were more than 90% identical to the ANN training data
(see Experimental Procedures), we evaluated the performance
of each predictor based on their receiver operating characteristic
(ROC) curves, which show sensitivity as function of false-positive
rate. We summarized each curve in a single number, the area
under the receiver operating characteristic curve (AROC), which
is a convenient performance measure because it does not
depend on defining a threshold to separate positive predictions
from negative ones. Provided that at least eight positive exam-
ples were left, we were able to benchmark 13 ANN and SMALI
predictors with an average AROC of 0.81 and 0.74, respectively
(Figure 4B). Since random performance corresponds to an
AROC of 0.5, both methods perform well in predicting in vivo
ligands of SH2 domains, even though the data used to develop
the methods were based on in vitro screens. However, NetSH2
has a competitive advantage because it is based on a larger
experimental data set and exploits a higher-order machine
learning, which in part can capture the complexity in the interac-
tion motifs that guide SH2-ligand binding.
Functional Prediction by Integration of Contextual
Information
While the ANN predictors of NetSH2 accurately capture and
model the actual binding site in a narrow sequence window,
they do not take into consideration evidence of the functional
relevance of the inferred SH2-mediated complex in a physiolog-
ical context. Thus, we integrated an additional prediction layer to
accommodate functional information (Linding et al., 2007). To
this end, we developed a ‘‘functional’’ confidence score that
was obtained by integrating, by a naive Bayes approach,
different contextual evidence. The contextual features that
were considered included (1) cellular colocalization, (2) tissue
coexpression, (3) predicted order/disorder, (4) degree of conser-
vation of the sequence of the peptide target in related species,
and (5) graph distance between the supposedly interacting
proteins in the human interactome. All of the considered features
contributed to a different extent to the performance of the
predictor (see Figure S5). The efficiency of the Bayesian predic-
tors, as compared with the ANN predictor, was evaluated by
drawing ROC curves and by calculating the AROC. Although
this analysis is statistically meaningful only for the few SH2
domains for which the ‘‘gold standard’’ of bona fide in vivo inter-
actors is sufficiently large, we can conclude that, in general, the
Bayesian predictor performs better than or equally as well as the
experimental score. The results of this analysis for two different
domains are displayed in Figures 4C and 4D. In the case of
PIK3R1 and GRB2, the Bayesian predictors clearly outperform
the ‘‘experimental’’ predictors (p values of 0.0006 and 0.1,
respectively). Bayesian functional scores were calculated for all
possible SH2 domain-phosphopeptide pairs; a total of 955,010
scores were stored in PepspotDB, along with the information
that was used to calculate the score.
PepspotDB: A Database for the Storage and Analysis of
Experiments based on Peptide Chip Technology
The SH2 interactome project yielded a large number of experi-
mental and computationally derived data points. To cope with
the associated data management challenge and facilitate the
fruition of the data and the integration with published information
in a single integrated resource,wehavedeveloped a newpublicly
accessible database, PepspotDB (http://mint.bio.uniroma2.it/
PepspotDB/home.seam) (see also Figure S6; Table S6).
PepspotDB contains four main data types: (1) raw and pro-
cessed experimental data points; (2) neural network predictions;
(3) literature curated interactions; and (4) Bayesian context
scores. In addition, PepspotDB is tightly integrated with the
protein-protein interaction database MINT (Licata et al., 2012).
All the neural network binding predictions on a set of 13,600
Figure 2. Sequence Logos Representing the Recognition Specificity of the SH2 Domain Family
For each SH2 domain, the peptides whose binding signal was higher than the average signal plus 2 SDs were aligned on the phosphorylated tyrosine. These
peptides were used to draw the peptide logos by a logo drawing tool implemented in PepspotDB (see Extended Results in Supplemental Information). Domain
logos of the same specificity class are framed in identical colors. The logo total information content is also indicated in each frame. See also Table S2.
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Figure 3. Classification of SH2 Domain Specificity
(A) To draw the recognition specificity tree, we computed the amino acid frequency at each of the13 positions of the SH2 binding peptides to compile a 73 (SH2
domains)3 240 (12 positions3 20 amino acids) matrix describing the domain specificity as amino acid frequencies at each of the 12 positions. We excluded from
the analysis the peptide position corresponding to the invariant phosphotyrosine. This matrix was used as input for EPCLUST (http://www.bioinf.ebc.ee/EP/EP/
EPCLUST/) to cluster the domains by using the algorithm ‘‘linear coefficient based distance, Pearson centered.’’ We next chose an arbitrary branch depth to
identify the 17 specificity classes highlighted with different colors in the figure.
(legend continued on next page)
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phosphopeptides retrieved from the PhosphoSite (Hornbeck
et al., 2004) and Phospho.ELM databases (Diella et al., 2008)
are also stored in the PepspotDB. Among the nearly one million
possible combinations of the 70 SH2-containing proteins and
13,600 phosphorylated tyrosine peptides, some 10,580 interac-
tions are supported by some signal observed in the peptide chip
experiment and 49,175 are computationally predicted by the
neural network algorithm, the overlap being 4,207 interactions.
This latter set of domain-peptide interactions with both experi-
mental and computational support is enriched in interactions
confirmed by published experiments (p value < 1.11$1016 by
the hypergeometric test) and can thus be deemed high
confidence.
PepspotDB comes with a rich web application providing
a user-friendly interface for easy information retrieval. The infor-
mation provided with each retrieved interaction includes exper-
imental, computational and contextual evidence supporting the
interaction, cross-references to MINT records describing an
interaction between the domain-containing protein and the
peptide-containing protein, and links to published articles re-
porting the currently displayed domain-peptide interaction.
Query results can be downloaded in text format for further anal-
ysis. See Extended Results for a more detailed description of the
database and a guide to its use.
Experimental Validation by Phosphopeptide Pull-Down
In order to validate the prediction based on peptide chip exper-
iments, we used 57 synthetic phosphopeptides linked to
magnetic beads to affinity-purify ligand proteins from extracts
of HeLa cells stimulated with epidermal growth factor (EGF).
(B) Amino acid logos for one representative domain for each specificity class.
(C) The SH2 domain sequenceswere alignedwith the ClustalW algorithm (4) and the homology tree was drawnwith the FigTree program (http://tree.bio.ed.ac.uk/
software/figtree1). Each domain name is highlighted with a background color corresponding to the specificity class in (A).
See also Table S3.
Figure 4. Benchmarking NetSH2 Predictors
(A) Distribution of the PCCs of the 70 NetSH2 predictors.
(B) Comparison of the AROC of 13 pairs of predictors tested against a literature-curated data set. Green bars represent the AROC of the SMALI PSSMpredictors,
while yellow bars are the AROC of the NetSH2 predictors presented here. *p < 0.05 (see Experimental Procedures).
(C and D) ROC curve obtained by plotting true positives versus false positives at a varying experimental (blue) or Bayesian (red) score using as a gold standard
a set of experimentally validated interactions extracted from the literature. The number of the gold standard interactions for PI3K and GRB2 were 31 and 24,
respectively.
See also Figure S4 and Table S4.
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To increase the statistical significance of the analysis, we inte-
grated already published data (25 phosphopeptide baits)
(Schulze et al., 2005) with new experiments (32 phosphopeptide
baits). This bait collection contains a large fraction of peptides
(Table S5) that are phosphorylated on tyrosines upon stimulation
of receptor kinases of the EGF receptor family. Affinity-purified
proteins were identified by liquid chromatography coupled to
high-resolution mass spectrometry. The recovered proteins
mostly contain SH2 domains, with a few exceptions. Overall,
these pull-down experiments define a network of 47 proteins
linked by 85 interactions (Figure 5A). Unlike ‘‘traditional’’ protein
interaction graphs, many proteins in this graph are represented
as covalently linked nodes, where each node is an independent
binding domain (Santonico et al., 2005). This representation is
Figure 5. Comparison between Experimen-
tally Verified and Predicted Interactions
(A) The graph represents all of the interactions
detected by pull-down experiments. Proteins are
labeled with their gene names. SH2-containing
proteins are represented as yellow circles, while
proteins containing target phosphopeptides are in
green. Proteins containing multiple SH2 target
sites are represented as covalently linked multiple
nodes labeled with the coordinates of the phos-
phorylated tyrosines. Interactions that are also
supported by the neural network predictors (Z
score > 2) are drawn in red.
(B) ROC curve obtained by plotting true positives
and false positives at varying neural network
score. The red curve is obtained by using a ranked
list limited to predictions of interactions with SH2
domains that have been identified in HeLa cells.
See also Figures S4, S5, and Tables S4, S5,
and S6.
made possible by the resolution of the
interaction information obtained by this
approach and allows us to distinguish
whether the interactions engaged by a
highly connected protein are mutually
exclusive or rather involve different bind-
ing regions and are mutually compatible.
Only 45 of the 125 SH2-containing
proteins have ever been identified by
liquid chromatography mass spectrom-
etry (LC-MS) experiments in HeLa cells
(Blagoev et al., 2004; Wisniewski et al.,
2009) (Table S6). For 28 of these we had
an SH2 specific neural network predictor
that could be used to rank the SH2
domains according to their preference
for the phosphopeptide baits. Approxi-
mately 33% of the interactions deter-
mined experimentally were ranked high
by the predictors developed in this work,
Z score higher than 2 (red edges in the
graph in Figure 5A). To measure the
performance of our predictors by a more
general approach, we plotted an ROC curve using the experi-
mentally derived SH2 containing proteins as positive instances
and the remaining as negative ones. The AROC was 0.81 with
a precision (true/false positives) of approximately 0.11 at a recall
of 50% (Figure 3B). However, there are a number of reasons why
the performance of our predictors is underestimated by this
analysis. First, some of the interactions that are predicted by
the neural network might have been missed by the affinity purifi-
cation experiment because of the low abundance of the corre-
sponding SH2 protein partners. In addition, some of the proteins
may bind to the bead-linked phosphopeptide by a domain that is
different from SH2. For instance, the protein SHC1 has a second
domain (PTB) that binds phosphopeptides containing theNPxpY
motif. Indeed, more than 50% of the phosphopeptides that
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affinity purified SHC1 contain this or related motifs. Finally, some
of the interactions detected by pull-down could be indirect. For
instance, SHC1 and GRB2 form a relatively stable complex
upon EGF induction. The SH2 domain of GRB2 binds peptides
containing a typical pYxN motif. The observation that SHC1
was detected in most of the pull-downs obtained with peptides
containing the pYxN GRB2 motif, despite having a different
recognition specificity, suggests that SHC1 binds this phospho-
peptide bead via a GRB2 bridge. Conversely, a SHC1 bridge
could explain the indirect binding of GRB2 to peptides contain-
ing an NPxpY motif. These considerations explain the relatively
poor performance of our SHC1 (and to a lesser extent GRB2)
SH2 domain predictor.
The EGF Dynamic Network
Protein interaction networks are typically pictured as static
graphs lacking a time dimension. However, most biological
processes are dynamic, and protein concentrations and modi-
fications change in time in response to external or internal
molecular cues. For instance, after addition of growth factors
such as EGF, the signal is propagated from the receptor on
the membrane to the nucleus via a cascade of modifications
(mostly additions and removal of phosphate groups), which in
turn promote the association and dissociation of enzymes
and adaptors containing phosphopeptide binding domains.
Olsen and colleagues (Olsen et al., 2006) have reported the
global in vivo phosphorylation dynamics following activation
of the EGF receptor in HeLa cells. Overall, they have identified
6,600 phosphorylation sites on 2,244 proteins containing at
least one phosphorylated Ser, Thr, or Tyr. Of the 293 phospho-
tyrosine peptides identified on 243 proteins, 53 dynamically
change their phosphorylation state after incubation with EGF.
We have combined this dynamic data set with our proteome-
wide prediction of the SH2 target sites to come up with
a description of the dynamic association and dissociation of
proteins following the activation of the tyrosine kinase signaling
cascade.
To this end, we downloaded from the HomoMINT database
(Chatr-Aryamontri et al., 2007; Persico et al., 2005) all of the inter-
actions where one of the partners is a protein participating in the
EGF pathway according to the Reactome database (Vastrik
et al., 2007). Only interactions with a MINT confidence score
(Chatr-Aryamontri et al., 2008) higher than 0.4 were considered.
This network represents the basal static interactions in the cell.
We next downloaded from PepspotDB all the interactions
between SH2-domain-containing proteins and the tyrosine-con-
taining peptides whose phosphorylation varies with time after
EGF stimulation. Interactions with a ‘‘final posterior probability’’
higher than 0.3, according to the Bayesian model developed
here, were taken into consideration. This inferred dynamic
network was superimposed onto the static literature-derived
network. For network legibility, all of the proteins linked to the
network by a single edge were removed. The predicted changes
occurring in the dynamic interactome are illustrated in Figure 6A,
where the proteins containing SH2 domains are in orange and
the interactions mediated by peptides whose phosphorylation
levels change after EGF stimulation are in red. Five minutes after
receptor stimulation, several EGF receptor peptides are phos-
phorylated and act as receptors for SH2-containing proteins.
Many of these interactions are predicted to vanish at time
20min while new ones, mediated by peptides that are phosphor-
ylated late, appear. Some of the inferred interactions, such as the
ones between the receptor and GRB2, SHC1, PLCG, or PI3K,
already have plenty of support in the literature. Some others
Figure 6. Dynamic EGF Network
(A) The four time-resolved graphs combine the information about (1) the kinetic
of tyrosine peptide phosphorylation following incubationwith EGF (Olsen et al.,
2006), (2) protein-protein interaction data mined from the literature, and (3) the
prediction of SH2 phosphopeptide interactions. Edges representing dynamic
interactions mediated by SH2 domains are in red, while orange and green
circles represent proteins containing or not containing SH2 domains,
respectively.
(B) GST fusions of three different SH2 domains (PI3K, GRB14, and SHP2) were
used in pull-down experiments after incubation of 500 mg of a HeLa cell extract
preincubated for 5 min with EGF. Affinity-purified proteins were analyzed by
SDS-PAGE and, after staining with Coomassie blue, transferred to mem-
branes and revealed with anti-phospho-ERK antibodies.
(C) After 16 hr starvation (time 0), HeLa cells were induced with EGF for 5, 10,
and 30 min. Protein extracts were incubated with the tandem SH2 domains of
SHP2 expressed as a GST-fusion protein. The affinity-purified SH2 ligands
were resolved by SDS-PAGE and revealed with anti-phospho-ERK antibody.
(D) After starvation, HeLa cells were treated with EGF for 5, 10, and 30 min.
Cellular lysates were separated by SDS-PAGE and transferred onto a nitro-
cellulosemembrane. The blot was incubated with anti-phospho-ERK and anti-
ERK antibodies.
(E) The whole protein extract (1 mg) of HeLa cells treated with EGF was
immunoprecipitated with anti-SHP2 antibody. Beads were washed with lysis
buffer and the immunoprecipitation (IP) was revealed with anti-phospho-ERK
and anti-SHP2 antibodies.
(F) HeLa cells were starved (00 min) or induced for 5, 10, and 30 min with EGF.
After cell lysis, 1 mg of protein extract was immunoprecipitated with anti-ERK
antibody and protein complexes (IP) were separated by SDS-PAGE and re-
vealed with anti-ERK and anti-SHP2 antibodies.
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have never been reported and might represent new functionally
important protein links.
We focused on the interactions mediated by the SH2 domains
of the phosphatase SHP2/PTPN11. SHP2 is known to be acti-
vated by binding to phosphorylated GAB1 (Holgado-Madruga
et al., 1996). This interaction releases the autoinhibitory binding
between the N-terminal SH2 domain and the phosphatase
domain, activates the phosphatase enzymatic activity, and, via
an incompletely understood mechanism, promotes a sustained
activation of extracellular signal-regulated kinase (ERK). Our
dynamic network recapitulates the interaction between the
SH2domains of SHP2 andGAB1, but in addition predicts a previ-
ously unrecognized interaction between the SH2 domains of
SHP2 and the phosphorylated Tyr204 in the activation loop of
extracellular signal-regulated kinase 1 or 2 (ERK1/2). The results
of the pull-down and coimmunoprecipitation experiments in
Figure 6B clearly show that SHP2 forms a dynamic complex
with ERK, starting 5 min after incubation with EGF. After
30 min, we observe a sharp decrease in the amount of
immunoprecipitated ERK, which parallels the reduction in ERK
phosphorylation levels.
The validation of the predicted dynamic interaction of SHP2
with ERK1/2 attests that the new experimental data presented
here, combined with orthogonal genome-wide context informa-
tion, contribute useful hints of new interactions to be experimen-
tally tested for functional relevance. The PepspotDB provides
easy access to these data and related predictions and thus
represents a useful resource to shed light on mechanisms that
rely on the formation of complexes mediated by phosphotyro-
sine peptides.
For a further explanation, please see the Extended Results.
EXPERIMENTAL PROCEDURES
Peptide Arrays
The 13-mer phosphotyrosine peptides were selected by combining the
2,198 peptides that were annotated in the Phospho.ELM (Diella et al.,
2008) and PhosphoSite databases (Hornbeck et al., 2004) at the time we
started this project and approximately 4,000 additional peptides from the
human proteome that received a high score by the NetPhos predictor
(Blom et al., 1999). Overall, 6,202 phosphopeptides, 13 residues long,
were synthesized and printed in triplicate identical arrays with appropriate
controls (Table S1).
Amino-oxy-acetylated peptides were synthesized on cellulose membranes
in a parallel manner using SPOT synthesis technology according to Frank
(1992) and Wenschuh et al. (2000). Following side-chain deprotection, the
solid-phase-bound peptides were transferred into 96 well microtiter filtration
plates (Millipore, Bedford, MA, USA) and treated with 200 ml of aqueous trie-
thylamine (2.5% by volume) in order to cleave the peptides from the cellulose
membrane. Peptide-containing triethylamine solution was filtered off and used
for quality control by LC-MS. Subsequently, solvent was removed by evapora-
tion under reduced pressure. Resulting peptide derivatives (50 nmol) were
redissolved in 25 ml of printing solution (70% DMSO, 25% 0.2 M sodium
acetate [pH 4.5], 5% glycerol; by volume) and transferred into 384 well micro-
titer plates. Different printing procedures (noncontact printing versus contact
printing) were tested for production of final peptide chips. The best results
were reached using contact printing with ceramic pin tools (48 in parallel) on
aldehyde-modified slides (enhanced surface; Erie Scientific). Printed peptide
microarrays were kept at room temperature for 5 hr, quenched for 1 hr with
buffered ethanolamine, washed extensively with water followed by ethanol,
and dried using microarray centrifuge. Resulting peptide microarrays were
stored at 4C.
A Large Manually Curated Data Set of Human SH2-Mediated
Interactions
Since the discovery that SH2 domains mediate binding to peptides containing
phosphorylated tyrosines (Anderson et al., 1990; Moran et al., 1990), several
reports have appeared in the literature describing the sequence of peptide
ligands for several SH2 domains. We have made an effort to recapture this
valuable information, organize it in a computer readable format, and store it
in a database. To this end, we have developed a simple text-mining approach
to recover from the Medline database abstracts containing the text ‘‘SH2’’ and
a ‘‘Y’’ followed by a number in a protein-interaction textual context. The recov-
ered abstracts were examined by expert curators, and whenever the abstract
hinted that the manuscript was reporting evidence for an interaction between
an SH2 domain and a specific phosphorylated peptide, the manuscript was
read through to extract the relevant information. Approximately 50% of the
abstracts recovered by text mining were deemed relevant by the curators.
When this work was in progress, we learned of a similar effort by Gong and
collaborators (Gong et al., 2008). The data curated by this group, including 489
SH2 related articles, are available in a public database. A total of 141 of the arti-
cles in our curation effort were not present in the PepCyber database, while
124 were in common. Among the entries in this latter collection, we found 20
discrepancies in the information extracted by the curators. These entries
were re-examined and the discrepancies fixed. Finally, the PepCyber data-
base contained 365 articles that were not yet curated in our effort. We analyzed
these 365 articles, and for 135 of them we could not find any experimental
evidence supporting an interaction between an SH2 domain and a specific
phosphorylated peptide. The remaining 230 articles were recurated by MINT
curators according to the Proteomics Standards Initiative molecular interac-
tion standards and controlled vocabularies (Hermjakob et al., 2004) (see
vent diagram in Figure S4).
Training and Benchmarking ANNs
In order to build predictors to infer if a given peptide is a weak or a strong ligand
of a particular SH2 domain, we employed ANNs of the standard three-layer
feed-forward type and encoded the amino acids as previously described (Niel-
sen et al., 2003). Only peptides with a length of 13 and with the phosphotyro-
sine residue centrally placed were taken into account. To avoid overfitting, the
data set was homology reduced using CD-HIT (Li and Godzik, 2006) with
default values and 90% sequence identity threshold. These operations
reduced the total data set from 6,202 peptides to 3,896. For each SH2 domain,
we normalized the log-ratio intensity values to range between 0 and 1, where
higher numbers correlate with stronger binding affinity. The data set was
divided into four subsets by random partitioning. We trained an ANN on two
subsets, determined the optimal network architecture and training parameters
on the third subset, and obtained an unbiased performance estimate from the
fourth subset. This was repeated in a round-robin fashion to utilize all data for
training, test, and validation. For each test set, the number of hidden neurons in
the ANN (0, 2, 4, 6, 10, 15, 20, and 30) was optimized according to the PCC.
The reported PCC performance measure of each ANN was based on the inde-
pendent validation subsets.
To validate the performance of developed ANNs, we used the data set of
known in vivo ligands of SH2 domains specifically curated for this work
(referred to the gold standard data set). This training-independent data set
served as the positive instances, while the negatives comprised 1,307 phos-
photyrosine peptides from Phospho.ELM (Diella et al., 2008) that have not
previously been shown to bind any SH2 domains. In order not to validate on
instances that are identical or highly similar in sequence to what was used
to train the ANNs, we used the BLAST algorithm to discard benchmark
peptides that were more than 90% identical to the training set. To compare
the performance of the ANNs with previously published methods, we ran the
benchmark data set through the SMALImethod that employs position-specific
scoring matrices to predict ligands of SH2 domains (Huang et al., 2008). We
tested each predictor on its respective validation set and calculated the
AROC for the SH2 domains for which we had at least eight positive instances
in the benchmark data set. To test if the observed performance of the PSSMs
was significantly different from the ANNs, we constructed bootstrap estimates
of the uncertainty associated with each AROC by resampling the score distri-
butions for positive and negative examples.
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Contextual Score Ranking Interactions according to Likelihood
of Functional Significance
The Bayesian model supporting the contextual score is based on a number of
independent genome-wide features describing the probability that the peptide
is exposed to the solvent or in a disordered part of the parent protein, that the
SH2 domain protein and its predicted partner are expressed in the same
tissues, and that they are close in the protein interaction network and
conserved in evolution. Finally, we have added the neural network score as
a property in the Bayesian inference scheme to give an overall probability of
interaction between the SH2 domain and the protein from which the peptide
in question was derived.
For each set of possible interactors (SH2-domain-containing protein and
peptide-containing protein), we retrieved information that could help deter-
mine whether that particular interaction is likely to take place under physiolog-
ical conditions.
The ‘‘tissue-specific expression’’ data were taken from Su et al. (2004), and
the subcellular localization was extracted partly from CellMINT (G.C., unpub-
lished data) and partly from Gene Ontology annotations. Both of these sets of
data were scored by counting the number of co-occurrences of organelle
terms and dividing by the highest number of occurrences for either the SH2
domain containing protein or the peptide containing protein, thus obtaining
a score between 0 and 1.
‘‘Structural disorder’’ was determined using IUPred by running the predic-
tion method on the full sequences and then cutting out the relevant part (Dos-
zta´nyi et al., 2005). A score between 0 and 1 was obtained by taking the
average score of all the residues constituting the peptide.
‘‘Degree of conservation’’ of the binding site in related species was evalu-
ated by inspecting it in multiple alignments of orthologs and paralogs from
ENSEMBL (Flicek et al., 2012). The relevant peptides were cut out of the
related sequences and evaluated for binding by the neural networks. The score
contribution for each orthologous sequence with the particular domain was
calculated by multiplying the neural network score with the overall sequence
distance from the original sequence obtained from a neighbor-joining tree.
This procedure was followed to award more to binding-site conservation in
distant sequences than to that in close sequences. The scores obtained
from all the orthologous sequences were added up to produce a single score
for each binding site/SH2 domain combination.
Conservation score = Si dist_sequencei * ANN_sequencei, where i runs
through all orthologous sequences in the alignment for that particular peptide.
Finally, the ‘‘raw neural network scores’’ were incorporated in the Bayesian
framework as a feature on its own.
To assess the importance of contextual evidence, we applied the naive
Bayes algorithm:
PðIjEÞ=PðIÞ  PðE1jIÞ  PðE2jIÞ:::PðExjIÞ
PðE1Þ  PðE2Þ:::PðExÞ
This computes the probability of interaction given the evidence [P(IjE)]. The
components of this calculation are the probabilities of seeing each piece of
evidence given interaction (PExjI) and the probability of seeing this evidence
in the full set of combinations of domain-containing proteins and peptides
P(Ex). In practice, this latter probability is calculated by evaluating both the
probability of the evidence given interaction and the probability of the evidence
given noninteraction (see Figure S5).
The parameters for themodel are determined from a set of known SH2 inter-
actions that was collected and curated manually, deemed ‘‘the foreground
set,’’ as well as the full range of possible combinations of SH2-domain-con-
taining protein and peptides (‘‘the background set’’), assuming that most of
these combinations are noninteracting in vivo.
Assembly of the EGF-Dependent Dynamic Network
The EGF-dependent dynamic network is a graph with a temporal dimension.
This is assembled via the following steps.
We first downloaded from theMINT database all of the interactions involving
as a partner one of the proteins that participate in signal transduction in the
EGF pathway, as described in the Reactome pathway database. Only interac-
tionswith aMINT confidence score greater than 0.4were considered. Next, we
inferred all the possible interactions between SH2-containing proteins and the
peptides described by Olsen et al. (2006) as phosphorylated in tyrosines
following EGF stimulation.
Phosphotyrosine Peptide Pull-Downs and Mass Spectrometric
Analysis
SILAC Cell Culture and Lysis
Adherent human cervix carcinoma cells (HeLa; ATCC number CCL-2) were
SILAC encoded in Dulbecco’s modified Eagle’s medium deficient in arginine
(Arg) and lysine (Lys) and supplemented with 10% dialyzed fetal calf serum
and antibiotics. One cell population was supplied with normal L-Arg and
L-Lys (‘‘light SILAC’’) and the other one with the stable isotope-labeled heavy
analogs 13C615N4-L-arginine and 13C615N2-L-lysine (‘‘heavy SILAC’’). After
five cell doublings, the cells were lysed in an ice-cold buffer consisting of 1%
NP-40, 150 mM NaCl, 50 mM Tris-HCl (pH 7.5), 1 mM dithiothreitol, protease
inhibitor mixture (Roche complete tablets), and 1 mM sodium ortho-vanadate
as tyrosine phosphatase inhibitor. Following centrifugation at 16,000 3 g for
15 min, the supernatant was used for peptide affinity pull-down experiments.
Peptide Synthesis
Peptides were synthesized as pairs in phosphorylated and nonphosphorylated
forms on a solid-phase peptide synthesizer using an amide resin (Intavis,
Germany) as previously described (Hanke and Mann, 2009). Briefly, an amino
acid sequence stretch of 13 residues surrounding the central in vivo tyrosine
phosphorylation site that we have previously identified by mass spectrometry
(Olsen et al., 2006) was synthesized with an N-terminal SerGly-linker and a N-
amino-modified desthiobiotin moiety for coupling to streptavidin-coated
beads and efficient elution via biotin. The purity of the all synthetic peptides
was confirmed by mass spectrometric analysis.
Peptide Pull-Down
Peptide pull-downs were performed automatically on a TECAN pipetting robot
using the peptide pull-down protocol described previously (Schulze et al.,
2005). The synthetic peptides were bound to streptavidin-coated magnetic
beads (Dynal MyOne, Invitrogen), and cell lysate corresponding to 1 mg of
protein (5 mg/ml protein) was added to 75 ml of beads containing an esti-
mated amount of 2 nmol of synthetic peptide. Heavy-SILAC-labeled lysate
was incubated with the phosphorylated version of the peptide, whereas
light-SILAC-labeled lysate was added to the nonphosphorylated counterpart.
After rotation at 4C for 4 hr, the beads were washed three times with lysis
buffer. Beads from each peptide pair were combined and bound proteins
were eluted using 20mMbiotin. Eluted proteinswere then precipitated by add-
ing 5 vol ethanol together with sodium acetate and 20 mg glycoblue (Ambion).
In-Solution Protein Digestion
The precipitated proteins were resuspended in 20 ml of 6 M urea, 2 M thiourea,
and 20 mM Tris-HCl (pH 8.0) and reduced by adding 1 mg of dithiothreitol for
30 min, followed by alkylation of cysteines by incubating with 5 mg iodoaceta-
mide for 20 min. Digestion was started by adding endoproteinase Lys-C
(Wako). After 3 hr, samples were diluted with 4 vol 50 mM NH4HCO3, and
trypsin (Promega) was added for overnight incubation. Proteases were applied
in a ratio of 1:50 to protein material, and all steps were carried out at room
temperature. Digestion was stopped by acidifying with trifluoroacetic acid,
and the samples were loaded onto homemade StageTips packed with
reverse-phase C18 disks (Empore, 3M, MN) for desalting and concentration
prior to LC-MS analysis.
Nanoflow LC-MS/MS
Digested peptide mixtures were separated by online reverse-phase nanoscale
capillary liquid chromatography and analyzed by electrospray tandem mass
spectrometry (MS/MS). Experiments were performed with an Easy-nLC nano-
flow system (Proxeon Biosystems) connected to an LTQ-Orbitrap XL or 7T-
LTQ-FT Ultra mass spectrometer (Thermo Fisher Scientific, Bremen,
Germany) equipped with a nanoelectrospray ion source (Proxeon Biosystems,
Odense, Denmark). Binding and chromatographic separation of the peptides
took place in a 15 cm fused silica emitter (75 mm inner diameter) in-house
packed with reverse-phase ReproSil-Pur C18-AQ 3 mm resin (Dr. Maisch
GmbH, Ammerbuch-Entringen, Germany). The mass spectrometer was oper-
ated in the data-dependent mode to automatically switch between high-reso-
lution orbitrap full scans (R = 60 K at m/z = 400) and LTQ ion trap CID of the top
ten most abundant peptide ions. All full scans were automatically recalibrated
in real time using the lock-mass option.
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Peptide and Protein Identification and Quantification
Peptide and proteins were identified by using Mascot and the MaxQuant soft-
ware suite (Cox and Mann, 2008) and filtered for an estimated false-discovery
rate of less than 1%. All SILAC pairs were quantified by MaxQuant, and the
corresponding protein ratios were calculated from the median of all peptide
ratios and normalized such that the median of all peptide ratios (log trans-
formed) was zero.
For further details, please refer to Extended Experimental Procedures.
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The domain-peptide interaction data have been deposited into a new publicly
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